Manufacturers often release new drugs into the market. While some drugs become popular among the masses, others draw criticism and incur losses for manufacturers. Such criticism could be warranted due to market realities, a poor competition strategy, a copayment, etc. However, one of the main reasons for the poor reception of a drug that frequently goes unnoticed is the selection of unsuitable prescription processing channels by the manufacturers. For additional information visit us at read more